Literature DB >> 23206928

M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.

Martina C Herwig1, Chris Bergstrom, Jill R Wells, Tobias Höller, Hans E Grossniklaus.   

Abstract

Macrophages have been found to be negative predictors of outcome in patients with uveal melanoma. In particular, recent studies point toward a disease-progressing role of proangiogenic M2 macrophages in melanomas with monosomy 3. Although most studies implicate a protective effect of PPAR-gamma activation in tumors, PPAR-gamma has also been shown to promote the polarization of M1 macrophages toward the M2 phenotype. The purpose of this investigation was first, to characterize the phenotype of tumor infiltrating macrophages and second, to study PPAR-gamma expression in uveal melanomas with molecular gene expression profile as prognostic predictors for patients' outcome. Twenty specimens from patients with uveal melanoma were analyzed for clinical and histologic tumor characteristics. The molecular RNA profile (class 1 or class 2) was commercially determined. Using immunohistochemical techniques, the specimens were dual labeled for CD68 and CD163. CD68 + CD163- M1 macrophages and CD68 + CD163+ M2 macrophages were analyzed in ten high power fields sparing macrophage-poor areas and a mean value was calculated for each tumor. The tumors were immunostained for von Willebrand factor and the micro vascular density (MVD) was analyzed according to Foss. To assess the proliferative rate of each tumor, Ki67 expression was evaluated in ten high power fields followed by calculation of a mean value. Expression of PPAR-gamma was evaluated using a score from 0 (no staining) to 3 (tumor entirely stained). Statistical analysis and a respective correlation were made between histologic characteristics, molecular profile, type of tumor infiltrating macrophages (M1 vs. M2), MVD, proliferative rate, and PPAR-gamma expression. Our results showed a correlation between the ratio of M2/M1 macrophages and the molecular profile with a ratio of approximately 1 corresponding to molecular class 1 and a ratio of approximately 2 corresponding to molecular class 2 (p = 0.01). The ratio of M2/M1 macrophages was higher in tumors with extraocular extension (p = 0.01). PPAR-gamma was predominantly expressed in the cytoplasm of tumor cells. Its expression showed no association with the molecular RNA profile (p = 0.83). This study confirmed that the ratio of M2/M1 macrophages is another prognostic factor in uveal melanoma. Thus, polarization of macrophages plays an important role for patients' outcome. PPAR-gamma is expressed in uveal melanoma tumor cells and further studies are warranted to determine its role in tumor biology.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206928      PMCID: PMC3556238          DOI: 10.1016/j.exer.2012.11.012

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  33 in total

Review 1.  The genetics of uveal melanoma: an emerging framework for targeted therapy.

Authors:  J William Harbour
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

2.  In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages.

Authors:  Long V Ly; Aabed Baghat; Mieke Versluis; Ekaterina S Jordanova; Gregorius P M Luyten; Nico van Rooijen; Thorbald van Hall; Pieter A van der Velden; Martine J Jager
Journal:  J Immunol       Date:  2010-08-16       Impact factor: 5.422

3.  Pigment epithelium-derived factor induces THP-1 macrophage apoptosis and necrosis by the induction of the peroxisome proliferator-activated receptor gamma.

Authors:  Tsung-Chuan Ho; Yuh-Cheng Yang; Show-Li Chen; Ping-Chang Kuo; Huey-Kang Sytwu; Huey-Chuan Cheng; Yeou-Ping Tsao
Journal:  Mol Immunol       Date:  2007-09-17       Impact factor: 4.407

Review 4.  Pathological and prognostic features of uveal melanomas.

Authors:  Ian W McLean; Vinicius S Saraiva; Miguel N Burnier
Journal:  Can J Ophthalmol       Date:  2004-06       Impact factor: 1.882

5.  Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.

Authors:  Willem Maat; Long V Ly; Ekaterina S Jordanova; Didi de Wolff-Rouendaal; Nicoline E Schalij-Delfos; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

6.  Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro.

Authors:  Christian Freudlsperger; Ingrid Moll; Udo Schumacher; Anka Thies
Journal:  Anticancer Drugs       Date:  2006-03       Impact factor: 2.248

7.  Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.

Authors:  Ajit A Kulkarni; Collynn F Woeller; Thomas H Thatcher; Sesquile Ramon; Richard P Phipps; Patricia J Sime
Journal:  PPAR Res       Date:  2012-06-18       Impact factor: 4.964

8.  Altered peroxisome-proliferator activated receptors expression in human endometrial cancer.

Authors:  Paweł Knapp; Adrian Chabowski; Agnieszka Błachnio-Zabielska; Katarzyna Jarząbek; Sławomir Wołczyński
Journal:  PPAR Res       Date:  2012-02-19       Impact factor: 4.964

9.  Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside.

Authors:  Angélica Amorim Amato; Francisco de Assis Rocha Neves
Journal:  PPAR Res       Date:  2012-06-14       Impact factor: 4.964

10.  Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice.

Authors:  Shiho Fujisaka; Isao Usui; Agussalim Bukhari; Masashi Ikutani; Takeshi Oya; Yukiko Kanatani; Koichi Tsuneyama; Yoshinori Nagai; Kiyoshi Takatsu; Masaharu Urakaze; Masashi Kobayashi; Kazuyuki Tobe
Journal:  Diabetes       Date:  2009-08-18       Impact factor: 9.461

View more
  26 in total

1.  Characterizing the Macrophage Response to Immunomodulatory Biomaterials Through Gene Set Analyses.

Authors:  Sarah E Blatt; Emily B Lurier; Gregory E Risser; Kara L Spiller
Journal:  Tissue Eng Part C Methods       Date:  2020-03       Impact factor: 3.056

2.  Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

Authors:  Manisha Singh; Hiep Khong; Zhimin Dai; Xue-Fei Huang; Jennifer A Wargo; Zachary A Cooper; John P Vasilakos; Patrick Hwu; Willem W Overwijk
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

3.  Distribution and clinical significance of tumour-associated macrophages in pancreatic ductal adenocarcinoma: a retrospective analysis in China.

Authors:  S J Chen; Q B Zhang; L J Zeng; G D Lian; J J Li; C C Qian; Y Z Chen; Y T Chen; K H Huang
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

4.  Inflammatory Variant of Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma of the Buccal Mucosa: An Overview and Case Report with a 10-Year Follow-Up.

Authors:  José Alcides Almeida de Arruda; Diego Antônio Costa Arantes; Lauren Frenzel Schuch; Lucas Guimarães Abreu; Bruno Augusto Benevenuto de Andrade; Mário José Romañach; Ricardo Alves Mesquita; Satiro Watanabe; José Carlos de Oliveira; Elismauro Francisco Mendonça
Journal:  Head Neck Pathol       Date:  2020-10-22

5.  Semaphorin3A increases M1-like microglia and retinal ganglion cell apoptosis after optic nerve injury.

Authors:  Liu Yun-Jia; Chen Xi; Zhang Jie-Qiong; Zhu Jing-Yi; Lin Sen; Ye Jian
Journal:  Cell Biosci       Date:  2021-05-26       Impact factor: 7.133

6.  4R-cembranoid protects neuronal cells from oxygen-glucose deprivation by modulating microglial cell activation.

Authors:  Hefei Fu; Jiapeng Wang; Jie Wang; Langni Liu; Jianxiong Jiang; Jiukuan Hao
Journal:  Brain Res Bull       Date:  2021-12-20       Impact factor: 4.077

7.  Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas--an immunohistochemical study.

Authors:  M Weber; P Moebius; M Büttner-Herold; K Amann; R Preidl; F W Neukam; F Wehrhan
Journal:  Br J Cancer       Date:  2015-06-25       Impact factor: 7.640

Review 8.  Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases.

Authors:  Su Zhang; Hongwei Gu; Nan Hu
Journal:  J Ophthalmol       Date:  2015-06-04       Impact factor: 1.909

9.  A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.

Authors:  Meiying Zhang; Yifeng He; Xiangjun Sun; Qing Li; Wenjing Wang; Aimin Zhao; Wen Di
Journal:  J Ovarian Res       Date:  2014-02-08       Impact factor: 4.234

10.  Different subsets of macrophages in patients with new onset tuberculous pleural effusion.

Authors:  Ying Tang; Shu-Cheng Hua; Gui-Xiang Qin; Li-Jun Xu; Yan-Fang Jiang
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.